Share. Connect. Create. Grow. · Socialiya
Why Sionna Therapeutics Stock Is Crashing 91% to a Record Low

is shelving its highly anticipated cystic fibrosis drug candidate, SION-719, after it failed to meet...

BUSINESS NEWS August 10, 2026

Why Sionna Therapeutics Stock Is Crashing 91% to a Record Low

is shelving its highly anticipated cystic fibrosis drug candidate, SION-719, after it failed to meet the key endpoint in a proof-of-concept trial.

5 views 0 likes 0 comments
Share:
is shelving its highly anticipated cystic fibrosis drug candidate, SION-719, after it failed to meet the key endpoint in a proof-of-concept trial.

Author: Barron's

Read Original Article

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya